Atlas Trials

To Evaluate the Safety, Tolerability and Pharmacokinetics of CT-P59 in Healthy Subjects

Clinical trial NCT04525079 · COMPLETED

Trial details

NCT number
NCT04525079
Sponsor
Celltrion
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
SARS-CoV-2 Infection
Start date
2020-07-18
Primary completion
2020-08-07
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.